COPD Trial, Recruiting NCT05724745 Sponsor: Commissariat A L'energie Atomique Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT05724745
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

All participants must meet these general criteria:

  • You must be able to understand what the study involves and what it is trying to achieve
  • You must be able to lie still inside an MRI scanner on your back for the full length of the scans
  • You must be able to give written consent freely and without pressure

If you are a healthy volunteer:

  • You are between 18 and 45 years old
  • You have no known or diagnosed lung conditions such as breathing failure, COPD, asthma, or lung cancer
  • You are able to lie completely still in an MRI scanner on your stomach for up to 50 minutes
  • You are a non-smoker and do not vape

If you have asthma:

  • You are between 18 and 80 years old
  • You are a non-smoker and do not vape
  • You have been diagnosed with moderate asthma (as defined by international asthma guidelines called GINA) for at least 6 months, OR you have been diagnosed with severe asthma for at least 6 months and your lung specialist is planning to start you on a biological therapy

If you have COPD:

  • You are between 40 and 80 years old
  • You have been diagnosed with moderate COPD (a specific lung function level known as GOLD 2) OR severe COPD (a specific lung function level known as GOLD 3) (confirm with trial site)

If you have had a double lung transplant and have a condition called BOS (a type of lung rejection):

  • You are between 18 and 90 years old
  • Your lung function (FEV1) has dropped irreversibly to below 80% of your personal baseline, with a specific breathing ratio below 0.7 (confirm with trial site)
  • Your CT scan does not show a mixed type of lung rejection condition called RAS/CLAD
  • You do not have a significant narrowing in your airways that has needed a procedure to treat it
  • Your diaphragm (the main breathing muscle) is working normally, confirmed by a specific test (confirm with trial site)

If you have had a double lung transplant and do NOT have BOS:

  • You are between 18 and 90 years old
  • Your lung function has stayed above 90% of your personal baseline for more than 24 months since your transplant
  • You do not have a significant narrowing in your airways that has needed a procedure to treat it
  • Your diaphragm is working normally, confirmed by a specific test (confirm with trial site)

Who may not be able to join:

  • Healthy volunteers who smoke or vape are not eligible
  • Healthy volunteers who have any known and diagnosed lung condition are not eligible
  • Asthma or COPD patients who smoke or vape are not eligible
  • Lung transplant patients who have a mixed type of rejection condition (called RAS/CLAD) are not eligible
  • Lung transplant patients who have had significant airway narrowing requiring a procedure are not eligible
  • Lung transplant patients whose diaphragm is not functioning normally are not eligible

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33169087460

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Commissariat A L'energie Atomique
Registry
ClinicalTrials.gov
Start date
26 May 2023
Est. completion
1 May 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Correlation between (1) spontaneous expiratory volume in 1 s (SEV1) and tidal volume (TV) and (2) FEV1 and FVC; Difference of expiratory volume in 1 s (SEV1) and tidal volume (TV) between the left and right lungs; Difference in expiratory volume in 1 s (SEV1) and tidal volume (TV) for the anterior-posterior, inferior-superior and medial-lateral lung regions

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov